hVIVO

Acquisition of CRS Berlin

hVIVO has announced the acquisition of CRS (Clinical Research Services) Berlin for a nominal upfront consideration and potential earn-out. It is a strategic bolt-on acquisition that has operated in close partnership with hVIVO following its previous acquisitions of CRS Mannheim and CRS Kiel in January 2025.

• Colin Grant
• Morning briefing
• Read Important Disclosures